Test Price
2,800 AED✅ Home Collection Available
MT‑TK Gene MERRF Syndrome (MT‑TK Related) Genetic Test in UAE
Executive Summary & Core Metrics
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO‑Certified Next‑Generation Sequencing (NGS) with orthogonal validation.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (available daily 8 AM – 11 PM).
- Clinical Guidance: Post‑test telephonic clinical correlation session with a DHA‑licensed consultant medical geneticist.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This non‑invasive genetic test screens the entire mitochondrial MT‑TK gene using Next‑Generation Sequencing (NGS) to detect pathogenic variants associated with Myoclonic Epilepsy with Ragged‑Red Fibers (MERRF) syndrome. It delivers definitive diagnostic clarity for at‑risk individuals and guides family planning.
| Feature | Our Test (NGS Full Gene) | Common Alternative (Targeted Mutation Panel) |
|---|---|---|
| Method | Next‑Generation Sequencing (full gene coverage) | Limited PCR‑based hotspot analysis |
| Diagnostic Sensitivity | >99.9% (all exons, intron‑exon boundaries) | ~70% (misses rare/novel variants) |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Clinical Reporting | DHA‑compliant interpretive report with pedigree integration | Raw variant list only |
Physician Insight & Safety Protocols
“This test is a powerful tool but must be interpreted within the full clinical picture. A negative result does not exclude mitochondrial disease, and incidental findings require expert counselling. I recommend pre‑test genetic counselling and post‑test follow‑up with a neurologist for any result.”
– Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403)
Advisory: Pre‑Test Genetic Counselling
A mandatory pre‑test session with a certified genetic counsellor is required to discuss implications, inheritance patterns, and to review family history. Consent forms will be signed before sample collection.
Exclusion Criteria & Emergency Red Flags
- Active acute illness or infection that may compromise sample stability – postpone draw.
- Known recent blood transfusion (within 4 weeks) – discuss with lab to avoid donor DNA interference.
- If you experience sudden seizure worsening, stroke‑like episodes, or respiratory distress, seek immediate emergency care – do not wait for test results.
- For minors, consent must be provided by a legal guardian, and the test must comply with UAE Federal Law No. 2 of 2019 concerning genetic testing in children.
Patient FAQ & Clinical Guidance
1. How accurate is this NGS test for detecting MERRF‑causing mutations?
Our full‑gene NGS sequencing covers all coding regions with >99.9% analytical sensitivity, detecting even low‑heteroplasmy variants down to 5% mutant load. This definitive molecular diagnosis allows precise risk assessment for family members.
2. Can I do this test at home, and how is the sample collected?
Yes, a DHA‑licensed phlebotomist visits your home (8 AM–11 PM) using a cold‑chain transport kit; you can provide a blood sample or an FTA card finger‑prick, and we manage the whole logistics chain under ISO 9001:2015 certification.
3. What should I do before the test?
A genetic counseling session is mandatory prior to sampling: you’ll provide a detailed family history to construct a pedigree chart, and if you take anticoagulants, please inform the nurse—no fasting is required unless your doctor advises otherwise.
UAE Regulatory & Data Privacy Adherence
Data Protection Compliance: This service adheres to Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is processed within UAE sovereign cloud infrastructure with strict access controls.
Clinical Safety: Patient consent and clinical procedures follow Federal Decree‑Law No. 4 of 2016 on Medical Liability. The test is performed under ISO 9001:2015 certified processes (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | MT‑TK Gene MERRF Syndrome (MT‑TK Related) Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA) or FTA Card Finger‑Prick |
| Methodology Used | Next‑Generation Sequencing (NGS) – Full MT‑TK Gene, 100x Coverage |
| ICD-10-CM Code | G40.309, G40.3 |
| LOINC Code | 81304-1 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians